Most skin cancers are preventable, if caught early, skin cancer is generally treatable. And yet, despite rapidly increasing rates and fervent warnings, not everyone is willing to apply sunscreen or stay in the shade. It is our responsibility to continue advancing our screening and monitoring options that catch skin cancer while it is still curable.
Melanoma is a malignancy of the melanocytes, and histology is the gold standard for distinguishing malignant cells from benign cells. Our robust menu of tools aid in dermatopathology diagnostics and treatment. Our portfolio of immunohistochemistry detection products delivers the high sensitivity and specificity you need from your assays. Our antibodies are ready-to-use on the fully-automated VENTANA BenchMark IHC/ISH staining platforms, reducing the time-to-result and resources required with manual or semi-automated solutions. In addtion, breakthroughs in biomarker and PCR research mean we now have diagnostic tools that offer not only early detection but also personalized skin cancer care, which enables oncology labs to test with confidence.